SpringWorks Therapeutics Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- SpringWorks Therapeutics's estimated annual revenue is currently $17.2M per year.
- SpringWorks Therapeutics received $103.0M in venture funding in September 2017.
- SpringWorks Therapeutics's estimated revenue per employee is $155,000
- SpringWorks Therapeutics's total funding is $103M.
- SpringWorks Therapeutics has 111 Employees.
- SpringWorks Therapeutics grew their employee count by 46% last year.
- SpringWorks Therapeutics currently has 1 job openings.
What Is SpringWorks Therapeutics?
SpringWorks Therapeutics is a mission-driven medicines company dedicated to developing innovative potential new treatments for unserved and underserved patient communities. Originally conceived by Pfizer, SpringWorks presents a groundbreaking new model for collaboration rooted in connecting scientists, biopharmaceutical partners, patient groups, funders and philanthropists to advance and deliver transformative science to patients. Through our partnerships, we remain focused on providing innovative treatments an additional avenue for development, with our launch pipeline focused on advancing potential programs for four diseases, all of which currently have no cure, including desmoid tumor, neurofibromatosis, hereditary xerocytosis and post-traumatic stress disorder. Our name is a reflection of our approach to drug development: we're springing into action to deliver treatments to people who are in great need and without alternatives.keywords:N/A